You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 150 No. 4, April 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIAL
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Corticosteroids for Croup

Reconciling Town and Gown

Peter C. Rowe, MD; Terry P. Klassen, MD

Arch Pediatr Adolesc Med. 1996;150(4):344-346.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AFTER SEVERAL decades of controversy, the efficacy of glucocorticoid therapy for children with croup is now substantiated by a consistent body of evidence from randomized controlled trials. Younger clinicians may not appreciate the acrimonious tenor of the corticosteroid-croup debate. As Smith1 wrote in 1989, "For many years, controversy has been the rule concerning this form of therapy, with battle lines drawn that have primarily, but not exclusively, separated the practitioner and the academician." In general, practitioner opinion favored and academician opinion opposed corticosteroids for croup.

In hindsight, clues about the efficacy of glucocorticoids were present from an early time. One of the first published comparative studies outlined most of the subsequently demonstrated benefits of glucocorticoids in this disease.2 A cumulative meta-analysis of the data (Figure) shows that by 1966, glucocorticoids were responsible for clinical improvement 12 hours after treatment (odds ratio, 2.36; 95% confidence interval, 1.75 to 3.18). . . . [Full Text PDF of this Article]


Author Affiliations

Department of Pediatrics The Johns Hopkins University School of Medicine Baltimore, Md; Department of Pediatrics University of Manitoba School of Medicine Winnipeg



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.